Bariatric surgery and its impact on cardiovascular disease and mortality: A systematic review and meta-analysis
Introduction
Obesity is a worldwide problem with significant consequences on individuals and society. The global age-standardized prevalence of obesity has nearly doubled from 6.4% in 1980 to 12% in 2008 [1]. Obesity is associated with cardiovascular disease, type 2 diabetes, several cancers, diminished average life expectancy, [2] and significant impairments in quality of life [3]. In addition, overweight or obesity in young adulthood and middle age has long-term adverse consequences for health care costs in older age [4]. Whilst people may reduce their weight by dieting, physical activity, behavioral modification or consumption of drugs such as orlistat, many people find it difficult to consistently maintain any reduction in weight [5]. Bariatric surgery is an option that has been shown to be associated with significant weight reduction compared to non-surgical control groups, and potentially confers improvements in disease conditions associated with obesity [6].
The effect of bariatric surgery on a number of endpoints has been extensively studied in the literature. Pontirroli et al. conducted a systematic review and meta-analysis of 8 studies with 44,022 participants and found that compared to controls, surgery was associated with a reduced mortality (OR 0.55 95% CI 0.49–0.63) [7]. Another meta-analysis has shown that bariatric surgery has significant benefits on cardiovascular risk factors including hypertension, diabetes and hyperlipidaemia [8]. In addition, there is evidence to suggest that it results in resolution of major comorbidities including metabolic syndrome, non-alcoholic fatty liver disease, nephropathy, left ventricular hypertrophy and obstructive sleep apnea [9]. However, there has yet to be a systematic review which evaluates the impact of bariatric surgery on cardiovascular events.
In this study, we performed a systematic review and meta-analysis to evaluate the impact of bariatric surgery on long-term incident cardiovascular disease and mortality.
Section snippets
Eligibility criteria
We selected randomized trials and controlled observational studies (cohort design) that evaluated the association of bariatric surgery and clinical outcomes. The following criteria were used for inclusion:
- 1.
sample size of > 100 participants undergoing bariatric surgery.
- 2.
control group consisting of participants with non-surgical management, either in the same healthcare setting or as community-based controls.
- 3.
aimed to evaluate one of the following outcomes: myocardial infarction/ischaemic heart
Results
Our search yielded 2764 potentially relevant articles and after removal of duplicates there were 2295 titles and abstracts, which were screened. There were 30 potentially relevant articles, the full text of these articles was retrieved and 14 studies met the inclusion criteria after full text review [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28]. The process of study selection is shown in Fig. 1.
The available study designs consisted of three prospective
Discussion
This is the first meta-analysis demonstrating that bariatric surgery is associated with a reduced risk of myocardial infarction, stroke and composite adverse cardiovascular events. The reduction in risk of these events was approximately 50% after bariatric surgery compared to non-operated cohorts. In terms of absolute event rates, we found that there were lower fraction of events in the bariatric surgery group compared to non-operated overweight control groups for all outcomes (mortality 3.6%
Conclusions
In conclusion, current observational studies provide consistent evidence that morbidly obese patients undergoing bariatric surgery have lower rates of myocardial infarction, stroke, cardiovascular events and mortality compared to matched non surgical controls (mortality 3.6% vs. 11.4%, cardiovascular events 2.4% vs. 4.0%, myocardial infarction 1.3% vs. 2.5% and stroke 0.8% vs. 1.5%). Whilst, our data does not infer a causal relationship, our analysis suggests that bariatric surgery may be
References (42)
- et al.
Obesity
Lancet
(2005) - et al.
Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls
Surg Obes Relat Dis
(2007) - et al.
Impact of gastric bypass operation on survival: a population-based analysis
J Am Coll Surg
(2004) - et al.
Natural history of morbid obesity without surgical intervention
Surg Obes Relat Dis
(2007) - et al.
The potential role of resistin in atherogenesis
Atherosclerosis
(2005) - et al.
National, regional and global trends in adult overweight and obesity prevalences
Popul Health Metrics
(2012) - et al.
Quality of life and obesity
Obes Rev
(2001) - et al.
Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age
JAMA
(2004) Nonsurgical management of obesity in adults
N Engl J Med
(2008)Bariatric surgery for morbid obesity
N Engl J Med
(2007)
Long-term prevention of mortality in morbid obesity through bariatric surgery: a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass
Ann Surg
Bariatric surgery and cardiovascular outcomes: a systematic review
Heart
Cardiovascular benefits of bariatric surgery in morbidly obese patients
Obes Rev
Chapter 14: adverse effects
The appropriateness of asymmetry tests for publication bias in meta-analysis: a large survey
CMAJ
When can odds ratios mislead?
BMJ
Measuring inconsistency in meta-analysis
BMJ
Long-term mortality after gastric bypass surgery
N Engl J Med
Health benefits of gastric bypass surgery after 6 years
JAMA
Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults
Obes Res Clin Pract
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
Ann Surg
Cited by (187)
Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis
2024, Clinics and Research in Hepatology and GastroenterologyAssociation of prior bariatric surgery with financial and clinical outcomes of acute myocardial infarction
2024, Surgery for Obesity and Related DiseasesEndometrial cancer patients understanding and interest in weight loss surgery
2023, Gynecologic OncologyThe role of weight control in the management of type 2 diabetes mellitus: Bariatric surgery
2023, Diabetes Research and Clinical PracticeThe fundamental role of obesity management in cardiometabolic risk reduction: nonpharmacological, pharmacological, and surgical approaches
2023, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine
- 1
This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.